\-\ Texto\\:\\ \ \(0\)\
\-\ wbc\\ 7400\\,\\ pmn\\ 64\\ \\%\\,\\ l\\ 23\\.6\\%\\,\\ mono\\ 8\\.4\\%\\,\\ e\\ 3\\.0\\%\ \(0\)\
\-\ esr\\ 124\\ \\ \\(1\\-19\\ mm\\/hr\\)\ \(0\)\
\-\ crp\\ 8\\.1\\ \\ \\(0\\.071\\ \\â\\€\\“\\ 5\\ mg\\/dl\\)\ \(0\)\
\-\ tissue\\ culture\\:\\ staphylococcus\\ auereus\ \(0\)\
\-\ amputation\\ of\\ distal\\ phalanx\\ and\\ systemic\\ antibiotics\\.\ \(0\)\
\-\ pa\\ radiograph\\ of\\ the\\ right\\ hand\\ shows\\ osteoarthritic\\ changes\\ of\\ the\\ dip\\,\\ pip\\,\\ and\\ first\\ mcp\\ joints\\ consistent\\ with\\ osteoarthritis\\.\\ \\ the\\ fifth\\ digit\\ demonstrates\\ soft\\ tissue\\ swelling\\ with\\ lysis\\ of\\ the\\ distal\\ phalanx\\.\ \(0\)\
\-\ osteomyelitis\ \(170\)\
\-\ osteomyelitis\ \(170\)\
\-\ gout\ \(75\)\
\-\ sarcoidosis\ \(108\)\
\-\ neoplasm\\ \\(e\\.g\\.\\,\\ pulmonary\\ metastasis\\ to\\ bone\\)\ \(0\)\
\-\ 74\\ yo\\ diabetic\\ male\ \(1\)\
\-\ this\\ diabetic\\ male\\ had\\ a\\ history\\ of\\ preceding\\ soft\\ tissue\\ infections\\ which\\ lead\\ to\\ numerous\\ amputations\\ of\\ digits\\ in\\ his\\ lower\\ extremities\\.\\ \\ his\\ most\\ current\\ episode\\ involved\\ a\\ refractory\\ soft\\ tissue\\ infection\\.\\ \\ \ \(0\)\
\-\ when\\ infection\\ sets\\ in\\,\\ there\\ are\\ local\\ metabolic\\ changes\\ and\\ inflamation\\ that\\ increase\\ necrosis\\.\\ \\ as\\ this\\ disease\\ progresses\\,\\ local\\ thrombophlebitis\\ occurs\\ which\\ increase\\ edema\\ and\\ intraosseous\\ pressure\\.\\ \\ this\\,\\ in\\ turn\\,\\ leads\\ to\\ the\\ development\\ of\\ sequestra\\,\\ an\\ ischemic\\ area\\ of\\ bone\\.\\ \\ once\\ the\\ cortical\\ bone\\ is\\ disrupted\\,\\ subperiosteal\\ abscesses\\ develop\\ with\\ inflammation\\ inducing\\ new\\ bone\\ formation\\ in\\ adjacent\\ soft\\ tissue\\.\\ \\ the\\ earliest\\ osseous\\ changes\\ by\\ plain\\ radiographs\\ are\\ osteopenic\\ or\\ lytic\\ lesions\\.\\ \\ this\\ requires\\ 30\\ to\\ 50\\%\\ decalcification\\ to\\ be\\ detected\\ and\\ take\\ 2\\ weeks\\ to\\ 1\\ month\\ to\\ develop\\.\\ \\ \ \(0\)\
\-\ brause\\,\\ b\\.\\ \\ \\"osteomyelitis\\.\\"\\ \\ cecil\\ textbook\\ of\\ medicine\\.\\ \\ 21st\\ edition\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.04727775401795127\ \(0\)\
\-\ diabetic\\:\\ 0\\.04049163775604913\ \(0\)\
\-\ tissue\\:\\ 0\\.04018692834231336\ \(0\)\
\-\ \\%\\:\\ 0\\.03955002050289697\ \(0\)\
\-\ phalanx\\:\\ 0\\.03773869375730221\ \(0\)\
\-\ auereus\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ decalcification\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ brause\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ 21st\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ develop\\:\\ 0\\.033822551844174265\ \(0\)\
\-\ bone\\:\\ 0\\.033705312404124915\ \(0\)\
\-\ soft\\:\\ 0\\.03303058355545317\ \(0\)\
\-\ 7400\\:\\ 0\\.03223163191827997\ \(0\)\
\-\ 23\\.6\\:\\ 0\\.03223163191827997\ \(0\)\
\-\ 0\\.071\\:\\ 0\\.03223163191827997\ \(0\)\
\-\ inducing\\:\\ 0\\.03223163191827997\ \(0\)\
\-\ local\\:\\ 0\\.031152137267815433\ \(0\)\
\-\ 1\\-19\\:\\ 0\\.03062264339404122\ \(0\)\
\-\ 8\\.1\\:\\ 0\\.03062264339404122\ \(0\)\
\-\ sets\\:\\ 0\\.03062264339404122\ \(0\)\
\-\ inflamation\\:\\ 0\\.03062264339404122\ \(0\)\
\-\ cecil\\:\\ 0\\.03062264339404122\ \(0\)\
\-\ pmn\\:\\ 0\\.029481047868438918\ \(0\)\
\-\ sequestra\\:\\ 0\\.029481047868438918\ \(0\)\
\-\ changes\\:\\ 0\\.029155333050417384\ \(0\)\
\-\ increase\\:\\ 0\\.028447696881840567\ \(0\)\
\-\ amputations\\:\\ 0\\.02787205934420017\ \(0\)\
\-\ 124\\:\\ 0\\.027260350297266606\ \(0\)\
\-\ preceding\\:\\ 0\\.02626307081996142\ \(0\)\
\-\ osteopenic\\:\\ 0\\.02626307081996142\ \(0\)\
\-\ mono\\:\\ 0\\.025844973535604967\ \(0\)\
\-\ earliest\\:\\ 0\\.025844973535604967\ \(0\)\
\-\ mm\\/hr\\:\\ 0\\.02546675853638146\ \(0\)\
\-\ 8\\.4\\:\\ 0\\.02480384550200381\ \(0\)\
\-\ lysis\\:\\ 0\\.02480384550200381\ \(0\)\
\-\ e\\.g\\.\\:\\ 0\\.02423598501136622\ \(0\)\
\-\ staphylococcus\\:\\ 0\\.02351248677012037\ \(0\)\
\-\ osteoarthritic\\:\\ 0\\.02351248677012037\ \(0\)\
\-\ pip\\:\\ 0\\.022900777723186803\ \(0\)\
\-\ disrupted\\:\\ 0\\.022900777723186803\ \(0\)\
\-\ subperiosteal\\:\\ 0\\.022900777723186803\ \(0\)\
\-\ progresses\\:\\ 0\\.022716174486540404\ \(0\)\
\-\ thrombophlebitis\\:\\ 0\\.022716174486540404\ \(0\)\
\-\ turn\\:\\ 0\\.022716174486540404\ \(0\)\
\-\ textbook\\:\\ 0\\.022716174486540404\ \(0\)\
\-\ dip\\:\\ 0\\.022539778603322812\ \(0\)\
\-\ intraosseous\\:\\ 0\\.022370891244518062\ \(0\)\
\-\ amputation\\:\\ 0\\.02220889920277102\ \(0\)\
\-\ mcp\\:\\ 0\\.02205326145216276\ \(0\)\
\-\ 3\\.0\\:\\ 0\\.020988721822818794\ \(0\)\
\-\ digit\\:\\ 0\\.020988721822818794\ \(0\)\
\-\ digits\\:\\ 0\\.020988721822818794\ \(0\)\
\-\ refractory\\:\\ 0\\.020988721822818794\ \(0\)\
\-\ crp\\:\\ 0\\.020761902720279318\ \(0\)\
\-\ edition\\:\\ 0\\.020245818878024565\ \(0\)\
\-\ e\\:\\ 0\\.02015019367334575\ \(0\)\
\-\ infection\\:\\ 0\\.019714417254546087\ \(0\)\
\-\ his\\:\\ 0\\.01954673831465819\ \(0\)\
\-\ take\\:\\ 0\\.019458315152929968\ \(0\)\
\-\ 74\\:\\ 0\\.019379733298580046\ \(0\)\
\-\ abscesses\\:\\ 0\\.01915291419604057\ \(0\)\
\-\ mg\\/dl\\:\\ 0\\.019080100153706456\ \(0\)\
\-\ gout\\:\\ 0\\.019008598147743447\ \(0\)\
\-\ leads\\:\\ 0\\.01893836173068233\ \(0\)\
\-\ fifth\\:\\ 0\\.01860469856714844\ \(0\)\
\-\ 64\\:\\ 0\\.018478711669074704\ \(0\)\
\-\ distal\\:\\ 0\\.018438718959889102\ \(0\)\
\-\ culture\\:\\ 0\\.018066819630655487\ \(0\)\
\-\ requires\\:\\ 0\\.018011318670438266\ \(0\)\
\-\ detected\\:\\ 0\\.01790259258239019\ \(0\)\
\-\ once\\:\\ 0\\.017352647489984847\ \(0\)\
\-\ esr\\:\\ 0\\.017170166881882373\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.01682860097405998\ \(0\)\
\-\ episode\\:\\ 0\\.016787900576571133\ \(0\)\
\-\ metabolic\\:\\ 0\\.01674761338822186\ \(0\)\
\-\ ischemic\\:\\ 0\\.016514119340511807\ \(0\)\
\-\ lead\\:\\ 0\\.016258014097902392\ \(0\)\
\-\ systemic\\:\\ 0\\.016222740497040308\ \(0\)\
\-\ infections\\:\\ 0\\.016118762828810054\ \(0\)\
\-\ medicine\\:\\ 0\\.016084700353844215\ \(0\)\
\-\ b\\:\\ 0\\.015984232861843063\ \(0\)\
\-\ current\\:\\ 0\\.01588624630394476\ \(0\)\
\-\ joints\\:\\ 0\\.015516839863206622\ \(0\)\
\-\ l\\:\\ 0\\.015458482135469733\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.015316235580814434\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.015260734620597212\ \(0\)\
\-\ this\\:\\ 0\\.015256146243081477\ \(0\)\
\-\ numerous\\:\\ 0\\.015205999215310165\ \(0\)\
\-\ lytic\\:\\ 0\\.015178912052332388\ \(0\)\
\-\ \\,\\:\\ 0\\.015039448084293743\ \(0\)\
\-\ development\\:\\ 0\\.014768921520475141\ \(0\)\
\-\ inflammation\\:\\ 0\\.014419582832041321\ \(0\)\
\-\ osseous\\:\\ 0\\.014397351659229137\ \(0\)\
\-\ involved\\:\\ 0\\.014223848440920284\ \(0\)\
\-\ pa\\:\\ 0\\.014181632575027204\ \(0\)\
\-\ formation\\:\\ 0\\.013997029338380805\ \(0\)\
\-\ hand\\:\\ 0\\.01393735522185485\ \(0\)\
\-\ occurs\\:\\ 0\\.013917661613354337\ \(0\)\
\-\ necrosis\\:\\ 0\\.01338532029144724\ \(0\)\
\-\ pressure\\:\\ 0\\.013317194086596583\ \(0\)\
\-\ extremities\\:\\ 0\\.013300343725955906\ \(0\)\
\-\ 30\\:\\ 0\\.013040037049424899\ \(0\)\
\-\ 50\\:\\ 0\\.012900785780332557\ \(0\)\
\-\ antibiotics\\:\\ 0\\.012736969673295639\ \(0\)\
\-\ metastasis\\:\\ 0\\.012693441771031454\ \(0\)\
\-\ which\\:\\ 0\\.012659877676528163\ \(0\)\
\-\ wbc\\:\\ 0\\.012361408137205602\ \(0\)\
\-\ cortical\\:\\ 0\\.012361408137205602\ \(0\)\
\-\ male\\:\\ 0\\.012263536014979945\ \(0\)\
\-\ to\\:\\ 0\\.011863003012305173\ \(0\)\
\-\ new\\:\\ 0\\.011816618955557771\ \(0\)\
\-\ neoplasm\\:\\ 0\\.011548240380602889\ \(0\)\
\-\ first\\:\\ 0\\.011378902518991476\ \(0\)\
\-\ swelling\\:\\ 0\\.011296868507861636\ \(0\)\
\-\ plain\\:\\ 0\\.0110129512408297\ \(0\)\
\-\ radiograph\\:\\ 0\\.010801383547306994\ \(0\)\
\-\ radiographs\\:\\ 0\\.010739170004770367\ \(0\)\
\-\ area\\:\\ 0\\.010721572397358202\ \(0\)\
\-\ adjacent\\:\\ 0\\.010721572397358202\ \(0\)\
\-\ yo\\:\\ 0\\.01020377588612207\ \(0\)\
\-\ month\\:\\ 0\\.010173073574605592\ \(0\)\
\-\ 5\\:\\ 0\\.009921271517635569\ \(0\)\
\-\ pulmonary\\:\\ 0\\.009906945675476442\ \(0\)\
\-\ when\\:\\ 0\\.009711631895301609\ \(0\)\
\-\ weeks\\:\\ 0\\.009624118082941065\ \(0\)\
\-\ edema\\:\\ 0\\.009590966227901947\ \(0\)\
\-\ shows\\:\\ 0\\.00932291150686063\ \(0\)\
\-\ are\\:\\ 0\\.009245030734361918\ \(0\)\
\-\ lesions\\:\\ 0\\.009077621056920428\ \(0\)\
\-\ \\(\\:\\ 0\\.008599544360045959\ \(0\)\
\-\ \\)\\:\\ 0\\.008494496334682203\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.008333869196951655\ \(0\)\
\-\ consistent\\:\\ 0\\.008314675669965091\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.00817360913485017\ \(0\)\
\-\ 1\\:\\ 0\\.008068755428411534\ \(0\)\
\-\ most\\:\\ 0\\.007828710879873317\ \(0\)\
\-\ lower\\:\\ 0\\.007626436783189931\ \(0\)\
\-\ demonstrates\\:\\ 0\\.007407226990687246\ \(0\)\
\-\ had\\:\\ 0\\.0073168643620663025\ \(0\)\
\-\ 2\\:\\ 0\\.007302001970279945\ \(0\)\
\-\ in\\:\\ 0\\.006688844922861189\ \(0\)\
\-\ that\\:\\ 0\\.0058570663831699335\ \(0\)\
\-\ by\\:\\ 0\\.005646313108114582\ \(0\)\
\-\ disease\\:\\ 0\\.005542609290538509\ \(0\)\
\-\ be\\:\\ 0\\.005229193346602893\ \(0\)\
\-\ as\\:\\ 0\\.005129275817040189\ \(0\)\
\-\ there\\:\\ 0\\.005046490303432494\ \(0\)\
\-\ an\\:\\ 0\\.0046891462868441655\ \(0\)\
\-\ history\\:\\ 0\\.004683391022647156\ \(0\)\
\-\ \\:\\:\\ 0\\.00448521752377248\ \(0\)\
\-\ of\\:\\ 0\\.004160850028499586\ \(0\)\
\-\ or\\:\\ 0\\.003974296622871855\ \(0\)\
\-\ the\\:\\ 0\\.00384025790843405\ \(0\)\
\-\ right\\:\\ 0\\.0035779036075810184\ \(0\)\
\-\ and\\:\\ 0\\.0035716072565916356\ \(0\)\
\-\ a\\:\\ 0\\.0031476174747508035\ \(0\)\
\-\ is\\:\\ 0\\.0022313126126378\ \(0\)\
\-\ \\.\\:\\ 0\\.0021130676248420402\ \(0\)\
\-\ with\\:\\ 0\\.0013929068582129729\ \(0\)\
